Analgesic Comparative Trials Urged; Placebo Still Standard for Approval
Executive Summary
FDA should encourage sponsors to conduct comparisons between standard analgesic therapies and newer agents, Arthritis Committee guest Mitchell Max, MD, National Institutes of Health, suggested